After the controversial 2011 ruling in Pliva v. Mensing, which confirmed federal preemption for generic drugs, plaintiffs who have suffered serious injuries when taking generic drugs have been seeking another way to recover damages. The court’s decision in 2011 generally gives generic drug makers im
On November 11, 2015, a Kansas woman filed a new Zofran lawsuit against manufacturer GlaxoSmithKline (GSK). She blames the company for failing to alert expectant moms to the risks of taking Zofran during pregnancy. The case was filed in the U.S. District Court for the…
If you’ve been watching your television lately, you may have seen it. It’s the new advertisement for Xarelto, the anticoagulant currently at the center of over 2,000 lawsuits because of the potential for excessive bleeding injuries. Manufacturer Janssen Pharmaceuticals, a subsidiary of Johnson & Joh
About a year ago, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. Since then, parties have been involved in pre-trial proceedings, including discovery and selection of potential bellwether cases
On October 29, 2015, a Chicago woman filed a new Onglyza lawsuit in the Cook County Circuit Court in Illinois. She claims that her mother died after taking the type 2 diabetes drug Onglyza (saxagliptin). Manufactured by AstraZeneca, Onglyza belongs to a class of drugs…
The FDA is being more cautious with testosterone replacement drugs. The administration recently put the brakes on the process to approve a new drug called “Androxal” (enclomiphene citrate), which is designed to treat men with low testosterone. Manufactured by a company called Repros Therapeutics, it
Another new Zofran lawsuit has been filed in federal court, and is likely to soon join the newly established Zofran MDL in the District of Massachusetts. The Plaintiff, a resident of Arkansas, filed the complaint in the Eastern District of Louisiana against Zofran manufacturer GlaxoSmithKline…
Manufacturers of the type 2 diabetes drug Invokana (canagliflozin) are facing another Invokana lawsuit recently filed in the Eastern District of California. The plaintiff, a resident of California, brings claims against Janssen Pharmaceuticals and parent company Johnson & Johnson for failing to warn
It’s been expected for awhile, and now it’s finally happened: the U.S. Judicial Panel on Multidistrict Litigation (JPML) has consolidated all federal Zofran lawsuits into one court, in the District of Massachusetts. District Judge Dennis Saylor, IV, was selected to oversee the proceedings. In the…
Onglyza (saxagliptin) is a type 2 diabetes medication that was approved by the FDA in 2009. It belongs to a class of drugs known as “incretin mimetics,” which stimulate the pancreas to make more insulin after the patient eats a meal, in order to keep…
Plaintiffs filing Xarelto lawsuits allege that manufacturers Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer AG failed to warn about a lack of antidote to Xarelto bleeding. Patients taking warfarin (the leading anticoagulant for decades) who suffer from uncontrollable bleeding
The U.S. Judicial Panel on Multidistrict Litigation (JPML) met on October 1, 2015, to hear oral arguments on consolidating all federally filed Zofran lawsuits into one court. Manufacturer GlaxoSmithKline (GSK) filed a motion with the panel on July 6, 2015, requesting consolidation in a multi-distric